Luca Aresu Selected Research

Luca Aresu Research Topics

Disease

24	Neoplasms (Cancer) 04/2024 - 11/2006
17	Lymphoma (Lymphomas) 11/2023 - 05/2013
7	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 05/2013
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 01/2014
3	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2020
3	Inflammation (Inflammations) 06/2012 - 11/2007
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2023 - 01/2019
2	T-Cell Lymphoma (Lymphoma, T Cell) 11/2023 - 05/2013
2	Osteosarcoma (Osteogenic Sarcoma) 12/2022 - 03/2020
2	Melanoma (Melanoma, Malignant) 02/2021 - 09/2019
2	Leukemia 01/2020 - 08/2019
2	Glomerulonephritis 08/2019 - 11/2007
2	Proteinuria 01/2015 - 01/2012
1	Hypoxia (Hypoxemia) 04/2024
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2023
1	Adenocarcinoma 12/2022
1	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2021
1	Pathologic Complete Response 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Disease Progression 09/2019
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 08/2019
1	Chronic Renal Insufficiency 08/2019
1	Aortic Coarctation 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Carcinogenesis 01/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Residual Neoplasm 05/2014

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 12/2022 - 12/2008
5	thiamine triphosphorate (TTP)IBA 04/2019 - 09/2013
4	Messenger RNA (mRNA)IBA 04/2022 - 07/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2024 - 05/2013
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2019
3	AntigensIBA 04/2022 - 04/2010
3	VimentinIBA 07/2016 - 11/2007
3	Matrix Metalloproteinases (MMPs)IBA 05/2013 - 07/2011
2	Rituximab (Mabthera)FDA Link 11/2023 - 01/2016
2	Monoclonal AntibodiesIBA 11/2023 - 12/2022
2	CreatinineIBA 08/2019 - 01/2012
2	VaccinesIBA 01/2019 - 02/2014
2	CateninsIBA 07/2016 - 12/2008
2	AntibodiesIBA 07/2016 - 11/2006
2	Keratins (Keratin)IBA 07/2016 - 11/2007
2	Cadherins (E-Cadherin)IBA 07/2016 - 12/2008
2	AlbuminsIBA 01/2015 - 01/2012
2	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2015 - 01/2012
2	Immunoglobulin G (IgG)IBA 01/2015 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 07/2011
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 05/2013 - 07/2011
1	cobaltous chloride (cobalt(II)chloride)IBA 04/2024
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 04/2024
1	DNA VaccinesIBA 04/2024
1	CXC ChemokinesIBA 04/2024
1	Protein Isoforms (Isoforms)IBA 04/2024
1	Oxygen (Dioxygen)IBA 04/2024
1	Carbonic Anhydrase IXIBA 04/2024
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 04/2024
1	naratuximab emtansineIBA 11/2023
1	Interleukin-6 (Interleukin 6)IBA 11/2023
1	Immunoconjugates (Immunoconjugate)IBA 11/2023
1	lisavanbulinIBA 01/2023
1	Pemetrexed (MTA)FDA Link 01/2023
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2023
1	BAL27862IBA 01/2023
1	ParaffinIBA 01/2023
1	ProdrugsIBA 01/2023
1	BI 2536IBA 12/2022
1	Polo-Like Kinase 1IBA 12/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	SB939 compoundIBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	toceranib phosphateIBA 03/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	NEO2734IBA 01/2020
1	Antigen-Antibody Complex (Immune Complex)IBA 08/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 06/2019
1	pqr620IBA 06/2019
1	Phosphotransferases (Kinase)IBA 06/2019
1	venetoclaxIBA 06/2019
1	TOR Serine-Threonine KinasesIBA 06/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2019
1	Sirolimus (Rapamycin)FDA Link 06/2019
1	NucleotidesIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 01/2015
1	Hexosaminidases (Hexosaminidase)IBA 01/2015
1	Sepharose (Agarose)IBA 01/2015
1	Antigen Receptors (Antigen Receptor)IBA 05/2014
1	Peptides (Polypeptides)IBA 02/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2014
1	Durapatite (Hydroxylapatite)IBA 02/2014

Therapy/Procedure

5	Immunotherapy 04/2024 - 01/2019
5	Drug Therapy (Chemotherapy) 06/2021 - 02/2014
5	Therapeutics 09/2020 - 08/2015
1	Adjuvant Chemotherapy 12/2022
1	Lymph Node Excision (Lymph Node Dissection) 10/2021
1	Conservative Treatment 02/2021
1	Anesthesia 01/2021
1	Radiotherapy 09/2019
1	CHOP protocol (VDCP protocol) 01/2019
1	Stents 01/2017